Hydralazine (Hydralazine Hydrochloride) - Summary

HYDRALAZINE SUMMARY

Hydralazine
Hydrochloride Injection,
USP

Hydralazine Hydrochloride Injection, USP is an antihypertensive available in a 1 mL vial for intravenous and intramuscular administration.

Hydralazine Hydrocloride (hydralazine) is indicated for the following:

Severe essential hypertension when the drug cannot be given orally or when there is an urgent need to lower blood pressure.

HYDRALAZINE NEWS HIGHLIGHTS

Published Studies Related to Hydralazine

Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial). [2007.08.15]

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. [2007.06]

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. [2007.04.03]

Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. [2006.09]

Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. [2006.08]

more>>

Clinical Trials Related to Hydralazine

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer [Completed]

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer [Terminated]

Hydralazine as a Demethylating Agent in Rectal Cancer [Withdrawn]

Hydralazine Valproate for Ovarian Cancer [Recruiting]

Hydralazine Valproate for Cervical Cancer [Recruiting]

more>>